1. Text: | Print|

      GSK probe indicates tightened drug sector supervision

      2013-07-19 08:39 Xinhua Web Editor: Mo Hong'e
      1

      An ongoing probe into suspected economic violations by multinational drugmaker GlaxoSmithKline (GSK) employees is being seen as part of efforts to tighten supervision in the medical sector.

      The Ministry of Public Security announced last week that some employees from GSK China are being investigated for suspected bribery and tax-related violations. Four senior executives from the company are being held by police over their alleged involvement.

      The probe has shed light on instances of hidden bribery that have driven up medicine prices. However, the case is not the first of its kind to be uncovered in China.

      In December last year, the U.S. Securities and Exchange Commission (SEC) charged Eli Lilly and Company for its involvement in instances of alleged bribery that occurred in several countries, including China.

      Four months before the Eli Lilly case, Pfizer's subsidiary in China was also found to have been involved in bribery.

      The GSK suspects are believed to have several methods of concealment, such as channelling bribes through travel agencies.

      It is believed that the exposure of the bribery represents just the tip of the iceberg.

      An anonymous medical salesman from north China's Tianjin Municipality said salesmen have had to come up with more creative ways to bribe doctors and convince them to raise the cost of their medicine.

      "In most cases, the doctors don't extort money in such explicit terms, but it is certain that they will not order products from those who do not give them a 'good return'," he said.

      The unfair market advantage that enterprises have gained by using bribery may make it harder for smaller companies to survive and develop. In addition, the costs of bribery are eventually transferred to patients.

      According to suspect Liang Hong, a medication that costs only 30 yuan to produce could end up setting patients back 300 yuan due to bribery.

      Bribery can also affect patients' health, as bribes may influence doctors' decisions regarding what medication to prescribe.

      A commerce official said Wednesday that the GSK probe is part of efforts to improve China's business climate and create equal competition opportunities for domestic and overseas investors.

      The official said China firmly opposes any form of commercial bribery, and all companies, Chinese and foreign alike, will be subject to legal sanctions and assume legal responsibility if they break Chinese law.

      Comments (0)
      Most popular in 24h
        Archived Content
      Media partners:

      Copyright ©1999-2018 Chinanews.com. All rights reserved.
      Reproduction in whole or in part without permission is prohibited.

      主站蜘蛛池模板: 日本高清免费aaaaa大片视频| 无码AV片在线观看免费| 亚洲va在线va天堂va手机| 亚洲中文字幕无码mv| 97在线视频免费公开视频| 无码国产精品一区二区免费虚拟VR| 亚洲第一黄色网址| 久久亚洲AV无码精品色午夜麻豆| 国内精品免费视频精选在线观看| 亚洲AV午夜成人片| 久久久久亚洲精品无码网址色欲 | 成全视频免费观看在线看| 国产亚洲精aa成人网站| 亚洲国产成人va在线观看网址| 16女性下面扒开无遮挡免费| 国产亚洲?V无码?V男人的天堂| 一级一黄在线观看视频免费| 国产亚洲日韩在线三区| 久久久久久国产精品免费免费男同| 99人中文字幕亚洲区| 免费无码A片一区二三区| 亚洲成a人片在线观看天堂无码| 免费一级毛片女人图片| 中文字幕免费在线看电影大全| 国产99视频免费精品是看6| 国产精品亚洲精品日韩电影| 18禁超污无遮挡无码免费网站国产 | 国产一级淫片a免费播放口之 | 亚洲人成无码久久电影网站| 全免费a级毛片免费看| 亚洲a∨无码男人的天堂| 免费国产综合视频在线看 | 国产美女a做受大片免费| 亚洲国产av一区二区三区丶| 久久久久国色AV免费看图片| 老司机午夜在线视频免费| 亚洲成AV人片在线观看无| 亚洲天堂免费在线视频| 亚洲精品视频在线观看你懂的| 美女视频黄的免费视频网页| 亚洲砖码砖专无区2023|